Key result
This review discusses the potential beneficial pleiotropic effects of statin therapy in reducing cardiovascular morbidity and mortality among women with polycystic ovary syndrome.
Why the study?
Does statin therapy reduce cardiovascular morbidity and mortality in women with polycystic ovary syndrome?
Does statin therapy reduce cardiovascular morbidity and mortality in women with polycystic ovary syndrome?
Statin therapy may offer pleiotropic benefits that reduce cardiovascular morbidity and mortality in women with polycystic ovary syndrome.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.
No takes yet. Share an insight, caveat, or question.
Sathyapalan et al. (2010) conducted a review in Polycystic ovary syndrome (PCOS). Statin therapy was evaluated. This review discusses the potential beneficial pleiotropic effects of statin therapy in reducing cardiovascular morbidity and mortality among women with polycystic ovary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: